BD Gets FDA Clearance for Combo Hospital-Acquired Infections Test | GenomeWeb
NEW YORK (GenomeWeb News) - The US Food and Drug Administration has cleared a Becton Dickinson DNA-based blood test for two common and dangerous hospital-acquired infections, the company’s BD Diagnostics segment said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.